Next Article in Journal
A Case Report on Longitudinal Collection of Tumour Biopsies for Gene Expression-Based Tumour Microenvironment Analysis from Pancreatic Cancer Patients Treated with Endoscopic Ultrasound Guided Radiofrequency Ablation
Previous Article in Journal
Virtual or In-Person: A Mixed Methods Survey to Determine Exercise Programming Preferences during COVID-19
 
 
Case Report

STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report

Department of Medical Oncology, Tianjin Medical University General Hospital, Tianjin 300052, China
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2022, 29(10), 6749-6753; https://doi.org/10.3390/curroncol29100530
Received: 28 August 2022 / Revised: 15 September 2022 / Accepted: 16 September 2022 / Published: 21 September 2022
(This article belongs to the Section Thoracic Oncology)
STRN-ALK fusion is a rare ALK rearrangement identified in non-small cell lung cancer (NSCLC) patients. Here, we reported a case of lung adenocarcinomas with brain metastasis, harboring STRN-ALK fusion, responded well to ensartinib. This case report could provide more information for the therapeutic strategy selecting of NSCLC patients harboring STRN-ALK fusion. View Full-Text
Keywords: STRN-ALK fusion; lung adenocarcinoma; brain metastasis; ensartinib STRN-ALK fusion; lung adenocarcinoma; brain metastasis; ensartinib
Show Figures

Figure 1

MDPI and ACS Style

Zhang, L.; Xiao, P.; Meng, F.; Zhong, D. STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report. Curr. Oncol. 2022, 29, 6749-6753. https://doi.org/10.3390/curroncol29100530

AMA Style

Zhang L, Xiao P, Meng F, Zhong D. STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report. Current Oncology. 2022; 29(10):6749-6753. https://doi.org/10.3390/curroncol29100530

Chicago/Turabian Style

Zhang, Linlin, Ping Xiao, Fanlu Meng, and Diansheng Zhong. 2022. "STRN-ALK Fusion in Lung Adenocarcinoma with Brain Metastasis Responded Well to Ensartinib: A Case Report" Current Oncology 29, no. 10: 6749-6753. https://doi.org/10.3390/curroncol29100530

Find Other Styles

Article Access Map by Country/Region

1
Back to TopTop